SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer) — SEC 8-K Filing
Supernus Pharmaceuticals→Navitor Pharmaceuticals
Apr 7, 2026
Track pharmacy acquisitions and investments within the healthcare sector.
Supernus Pharmaceuticals→Navitor Pharmaceuticals
Apr 7, 2026
Esperion→Corstasis Therapeutics
Apr 6, 2026
Shionogi→RADICAVA (edaravone) global rights from Tanabe Pharma
Apr 3, 2026
Rocket Pharmaceuticals
Apr 3, 2026
OneroRx→NuCara Specialty Pharmacy
Apr 3, 2026
Athyrium Capital Management→Esperion Therapeutics
Apr 2, 2026
Esperion Therapeutics→Corstasis Therapeutics
Apr 2, 2026
Apr 2, 2026
Piramal Pharma→Kenalog Injectable Product
Apr 1, 2026
CapVest→STADA Arzneimittel
Apr 1, 2026
Eris Lifesciences→Velbiom Probiotics
Mar 31, 2026
Eli Lilly→Centessa
Mar 31, 2026
Athira Pharma→Sermonix Pharmaceuticals
Mar 31, 2026
Jubilant Ingrevia→Remidex Pharma
Mar 30, 2026
Aurinia Pharma→Kezar Life Sciences
Mar 30, 2026
Iterum Therapeutics
Mar 27, 2026
Merck→Terns Pharmaceuticals
Mar 26, 2026
Merck Sharp & Dohme→Terns Pharmaceuticals
Mar 25, 2026
Novartis→Pikavation Therapeutics
Mar 20, 2026
Collegium Pharmaceutical→Corium Therapeutics
Mar 19, 2026